Minneapolis Heart Institute (Foundation)
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Traverse, Jay
MINT, NCT02981407: Myocardial Ischemia and Transfusion

Completed
3
3506
Europe, Canada, US, RoW
Red Blood Cell Transfusion
Rutgers, The State University of New Jersey, University of Pittsburgh, National Heart, Lung, and Blood Institute (NHLBI)
Myocardial Infarction, Anemia
05/23
10/23
NCT05305911: Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Recruiting
2
80
US
Dapagliflozin, Placebo
Minneapolis Heart Institute Foundation
Heart Attack, Enlarged Heart
04/24
04/24
GenePHIT, NCT05598333: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

Recruiting
2
150
US
AB-1002, Gene Therapy, NAN-101
Asklepios Biopharmaceutical, Inc.
Congestive Heart Failure
10/26
12/30
NAN-CS101, NCT04179643: NAN-101 in Patients With Class III Heart Failure

Recruiting
1
12
US
3 x 10e13vg NAN-101
Asklepios Biopharmaceutical, Inc.
Congestive Heart Failure, Heart Failure, Heart Disease, Ischemic, Cardiovascular Diseases, Heart Failure, Systolic, Heart Failureļ¼ŒCongestive, Heart Arrhythmia, Heart Failure, Diastolic, Heart; Complications
12/26
12/26
TARGET-IV_NA, NCT04562532: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Active, not recruiting
N/A
1720
Europe, Canada, US
Microport Firehawk stent, MicroPort Firehawk rapamycin target eluting stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
Shanghai MicroPort Medical (Group) Co., Ltd.
Coronary Artery Disease
06/24
06/27
Peterson, Rose
No trials found

Download Options